This post is part of an ongoing series summarizing state-based psychedelic reforms intended for policy professionals.
On Aug. 27, the Interim Joint Committee on Health Services discussed whether Kentucky should join a multi-state collaborative to conduct clinical trials of ibogaine as a treatment for certain neurological conditions, including opioid addiction. In 2023, the Kentucky Opioid Abatement Advisory Commission first broached the idea of directing a portion of the state’s ...
“Once you turn that invisible line, there’s no going back,” said UFC legend Mark Kerr, speaking to Sports Illustrated about his addiction. Fans knew him as ‘The Smashing Machine.’ Kerr captured two UFC heavyweight titles after debuting in the promotion in 1997. At his peak, he dominated opponents and looked unstoppable inside the Octagon. However, away from the spotlight, his life veered into a darker fight. Kerr battled prescription painkillers and ...
In the high-stakes world of professional sports, where concussions and chronic traumatic encephalopathy (CTE) cast long shadows over athletes’ careers and post-retirement lives, a controversial treatment is gaining quiet traction among NFL and UFC veterans. Ibogaine, a potent psychedelic derived from the African iboga shrub, is being sought out by players desperate for relief from brain trauma symptoms, despite its classification as a Schedule 1 controlled substance in the U.S. with no approved ...
“As awareness grows around the dangers of head trauma in sports, a small number of professional fighters and football players are turning to a psychedelic called ibogaine for treatment,” reports the Los Angeles Times.
They note that the drug’s proponents “tout its ability to treat addiction, post-traumatic stress disorder and traumatic brain injury, or TBI. ”
Ibogaine, which is derived from a West African shrub, is a Schedule ...
What drives Universal Ibogaine Inc JC4 stock price ✌️【Stock Watchlist】✌️ We help you ride the next big wave in the stock market — 200%+ gainers …